Join PharmaDispatch
Subscribe
Login
Explore the Site
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BioPharmaDispatch
Menu
February 18, 2026
Subscribe
Login
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Latest Video
Georgia Forrest
Most Read
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - Latest News
PhRMA targets the PBS, urges 'Priority Watch List' inclusion over policy failings
February 17, 2026 - Latest News
Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines
February 16, 2026 - Latest News
'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'
February 16, 2026 - Latest News
Life sciences sector unites to advance women’s leadership at landmark 2026 events
February 16, 2026 - Latest News
Follow Us
LinkedIn
Twitter
Instagram
New Stories
Telix files for European approval of brain cancer imaging candidate TLX101-Px
February 18, 2026 - - Australian Biotech
IDT signals turnaround as revenue rises and losses narrow under strategic reset
February 18, 2026 - - Latest News
Nyrada advances lead candidate into mid-stage trial as momentum builds across programs
February 18, 2026 - - Australian Biotech
Novo Nordisk backs community-led initiative that aims to transform life for Logan’s children
February 18, 2026 - - Latest News
CSL and Lilly strike strategic deal to advance promising anti-inflammatory therapy
February 18, 2026 - - Latest News
Targeted blood cancer treatments proposed for funding in New Zealand
February 18, 2026 - - Latest News
Percheron targets next wave of immunotherapy with novel VISTA checkpoint candidate
February 18, 2026 - - Australian Biotech